Health Catalyst, Inc. (HCAT) Cut to Equal Weight at Wells Fargo on Prolonged Revenue, Margin Pressure [Yahoo! Finance]
Health Catalyst (HCAT) was downgraded by Wells Fargo & Company from "overweight" to "equal weight". They now have a $1.00 price target on the stock.
Health Catalyst (HCAT) had its price target lowered by Citigroup Inc. from $2.75 to $1.75. They now have a "neutral" rating on the stock.
Health Catalyst (HCAT) had its price target lowered by Stephens from $3.50 to $2.00. They now have an "equal weight" rating on the stock.
Health Catalyst (HCAT) had its price target lowered by Stifel Nicolaus from $3.75 to $2.00. They now have a "hold" rating on the stock.